Introduction: A Question of Both Healing and Holiness
Few areas of modern medicine hold more genuine promise — or raise sharper moral questions for the Christian — than stem cell research. The prospect of repairing a damaged heart, restoring sight, halting the tremors of Parkinson’s disease, or rebuilding a failing immune system is no longer science fiction. In laboratories and clinics around the world, stem cell therapies are moving from theory into the lives of real patients.
But not all stem cell research stands on the same moral ground. The believer is called to weigh these matters carefully, because one major branch of this field — embryonic stem cell research — cannot be pursued without the deliberate destruction of human life at its earliest stage. The good news, which this article will demonstrate from the scientific record itself, is that the two most successful and clinically proven approaches to stem cell medicine carry no such moral burden. The Christian need not choose between faithfulness to God and the pursuit of healing. The ethical paths are also, by a wide margin, the more fruitful ones.
I. What Is a Stem Cell?
A stem cell is an unspecialized cell with two remarkable abilities: it can renew itself through division, and it can develop into specialized cell types — nerve cells, muscle cells, blood cells, and so on. This is what makes stem cells so valuable to medicine: in principle, they can replace cells that disease or injury has destroyed.
Stem cells are classified by how many different cell types they can become. Pluripotent cells can become nearly any cell type in the body. Multipotent cells are more limited, producing a related family of cell types. The great ethical divide in this field is not about the science of what these cells can do, but about where they come from. There are three principal sources, and they are worlds apart morally.
II. Adult Stem Cells: The Proven Workhorse
Adult stem cells (also called somatic or tissue stem cells) are found throughout the mature human body — in bone marrow, blood, fat, skin, and many organs. They are typically multipotent, repairing and maintaining the tissue in which they reside. Crucially, harvesting them harms no one; a bone marrow or blood donation is given freely by a consenting adult.
These are not a speculative hope. Adult stem cells are the foundation of the only category of stem cell therapy with a long, established record of saving lives. Bone marrow transplantation — which is a hematopoietic (blood-forming) stem cell transplant — has been used for more than half a century to treat leukemia, lymphoma, and other blood cancers. As of the most recent figures, well over a million such transplants have been performed worldwide, and the technique remains one of the most clinically validated interventions in all of medicine.
The list of approved adult stem cell therapies has grown steadily. Recent United States Food and Drug Administration approvals include Omisirge (2023), a cord-blood-derived graft that speeds immune recovery after transplantation; Ryoncil (2024), the first mesenchymal stem cell therapy approved for steroid-resistant graft-versus-host disease in children; and a number of umbilical cord blood products used for reconstituting the blood and immune system. Mesenchymal stem cells — drawn from bone marrow, fat, and umbilical cord tissue — are being studied for diabetes, heart attack damage, stroke, and the diabetic complications that lead to limb loss.
III. Induced Pluripotent Stem Cells: The Ethical Breakthrough
For years, scientists who wanted pluripotent cells — cells able to become almost any tissue — believed they had to obtain them from embryos. That changed in 2006, when the Japanese scientist Shinya Yamanaka made one of the most important discoveries in modern biology. By introducing just four genes into an ordinary adult cell, such as a skin cell, he was able to “reprogram” it backward into a pluripotent state. These reprogrammed cells are called induced pluripotent stem cells, or iPSCs. Yamanaka was awarded the Nobel Prize in 2012, only six years later — a measure of how significant the breakthrough was. In 2007, James Thomson’s team at the University of Wisconsin-Madison achieved the same feat with human cells.
The moral significance is profound. iPSCs give scientists the full flexibility of pluripotent cells without the use or destruction of a single embryo. A patient’s own skin or blood cell can be reprogrammed, meaning the resulting therapy is also genetically matched to that patient, reducing the risk of immune rejection.
And the science is delivering. The first transplant of iPSC-derived cells into a human took place in Japan in 2014, treating macular degeneration of the eye. Since then the field has accelerated dramatically. As of 2025, researchers had identified roughly ten published clinical studies and more than twenty registered ongoing trials using iPSCs to treat conditions including heart disease, eye disorders, cancer, and graft-versus-host disease. In 2025, two landmark trials published in the journal Nature reported encouraging results using iPSC-derived dopamine-producing cells to treat Parkinson’s disease — cells that replace exactly what that disease destroys. A first-in-human study published in The Lancet in 2024 used iPSC-derived corneal tissue to restore damaged eyes. The first United States clinical trial of an iPSC-derived therapy, for an advanced eye condition, is now underway.
IV. Embryonic Stem Cells: The Unbiblical Method
Embryonic stem cells are obtained from a human embryo at roughly five to eight days after fertilization, at a stage called the blastocyst. To extract these cells, the embryo is destroyed. This is the heart of the moral problem, and no amount of careful language can move around it: a living human embryo must die for its cells to be harvested.
Defenders of the practice typically argue that the embryos used are “surplus” embryos left over from in vitro fertilization that would be discarded anyway, and that the potential to relieve enormous human suffering justifies their use. But this reasoning fails on its own terms. That a human life may be discarded by others does not grant anyone the right to destroy it; and a good end has never, in Christian ethics, sanctified an evil means. Paul the Apostle confronted this very logic directly:
For the Christian, the destruction of the embryo is not a regrettable side effect to be weighed against benefits. It is the deliberate taking of an innocent human life, and that places embryonic stem cell research outside the bounds of what a believer may support or participate in.
V. When Does Human Life Begin? Scripture and Science Agree
The entire ethical dispute hinges on a single question: is the embryo a human being? Here the Christian position is not a retreat into blind faith against science — it is, remarkably, the position most consistent with the biological facts.
The Witness of Scripture
The Bible consistently treats the unborn, from the earliest stage, as a human person known and valued by God. David writes:
God says to Jeremiah:
When Mary, newly carrying the Lord Jesus, visited Elisabeth, the unborn John the Baptist responded to the presence of the unborn Christ:
Throughout Scripture there is no category of “potential person” or “pre-human tissue.” The being in the womb is a child, known by God, with a future and a calling, from the very beginning.
The Witness of Biology
Modern embryology confirms what Scripture has always declared. At the moment of fertilization, a new organism comes into existence with a complete and unique set of human DNA, distinct from both mother and father, directing its own development. The zygote is, as the science textbooks themselves describe, genetically identical to the embryo it becomes, which is identical to the fetus, which is identical to the newborn, the child, and the adult. There is no later point at which a different kind of being suddenly appears; there is only continuous growth of one and the same human individual.
This is why the personhood arguments offered by defenders of embryonic research are so revealing. Because biology offers no natural dividing line, those who wish to use embryos must invent one. Various proposals have been offered: that personhood begins at fourteen days (when the “primitive streak” forms and twinning is no longer possible), at implantation, at the first heartbeat, at the onset of brain activity, at viability outside the womb, or even at birth. The very multiplicity of these proposed lines exposes the problem. As bioethicists on both sides concede, the criteria for personhood are “notoriously unclear,” and each proposed boundary is ultimately arbitrary — chosen not because biology demands it, but because it permits the research the proposer wishes to do.
Even some honest secular scientists admit the difficulty. As one developmental biologist writing in Cell Stem Cell acknowledged, the question “When does life begin?” tends to interest politicians and philosophers more than the biologists who actually study fertilization, precisely because, biologically, life is a seamless continuum with no obvious break. The Christian simply takes that continuum to its logical and honest conclusion: if there is no non-arbitrary line after fertilization, then the only consistent and safe position is to regard the embryo as a human being from conception.
| Proposed Start of Personhood | The Problem With It |
|---|---|
| Fertilization (the biblical and pro-life view) | Marks the one clear, non-arbitrary point at which a new, complete, self-directing human organism begins to exist. |
| 14 days / “primitive streak” | An arbitrary line chosen largely because it is the legal limit for embryo experiments; the embryo is fully human before and after. |
| Implantation in the womb | A change of location and nourishment, not a change in the nature of the being; the embryo is the same individual before and after. |
| First heartbeat or brain activity | Marks the maturing of organs the embryo was already building; the human being existed before these organs functioned. |
| Viability outside the womb | A moving target that shifts with medical technology — meaning personhood would depend on the era and hospital, not on the child. |
| Birth | Only a change of location; a full-term infant the day before birth is biologically indistinguishable from one the day after. |
VI. Is There Greater Emphasis on the Unethical Method?
One might expect that, with two ethical and increasingly successful alternatives available, the research world would have quietly set embryonic stem cells aside. The reality is more complicated, and it tells us something about the priorities at work.
It is true that practical, clinical progress has come overwhelmingly from the ethical methods. Adult stem cells account for essentially all the long-established, FDA-approved stem cell therapies, and iPSCs now dominate the new wave of clinical trials. Embryonic stem cells, despite decades of funding and intense promotion, have produced remarkably few therapies that have reached patients.
And yet a significant portion of the scientific establishment continues to insist that embryonic stem cell research must not be reduced. As recently as 2026, when the United States National Institutes of Health paused new submissions to its embryonic stem cell registry and issued a formal request for information on reducing reliance on these cells, major research organizations reacted with alarm. The International Society for Stem Cell Research publicly urged the NIH to reverse course, arguing that embryonic cells remain an “irreplaceable” benchmark and that iPSCs, while valuable, cannot fully substitute for them because the two cell types can be distinguished at the genetic level.
There is a legitimate scientific point buried in that claim — embryonic and induced cells are not perfectly identical, and embryonic cells have long served as the reference standard against which iPSCs are measured. But the intensity of the defense, in the face of the ethical alternative’s clear clinical superiority, is striking. For the Christian observer it raises a fair question: why such determination to preserve access to a method that destroys human life, when the ethical methods are the ones actually healing patients? The honest answer, at least in part, is that a research model once committed to is difficult to abandon, and that a worldview which does not recognize the embryo as a human being feels no urgency to find another way.
VII. Two Ethical Paths the Believer Can Walk
The encouraging conclusion of this whole survey is that the Christian facing serious illness — or supporting a loved one who is — is not shut out of the promise of stem cell medicine. The two methods that are both biblically permissible and clinically most successful are available and advancing rapidly.
The most proven path. If you or a loved one faces leukemia, lymphoma, another blood cancer, certain immune disorders, or specific approved conditions, hematopoietic stem cell transplantation is a decades-established, life-saving therapy. Newer mesenchymal and cord-blood therapies are extending the reach of this approach. Because the cells come from consenting adult donors, umbilical cords donated after healthy birth, or the patient’s own body, no human life is destroyed.
Biblically clean, clinically proven, and widely available.
The most promising frontier. iPSCs offer the full power of pluripotent cells with none of the moral cost, and often with the patient’s own genetic match. The therapies are mostly still in clinical trials — for Parkinson’s disease, heart failure, eye disease, and more — but they are progressing quickly and represent the likely future of regenerative medicine. A believer can support, fund, and in time receive these therapies with a clear conscience.
Biblically clean, scientifically cutting-edge, and rapidly advancing.
A practical word of caution belongs here as well. The genuine promise of stem cells has unfortunately spawned a great many unregulated clinics, particularly abroad, that market expensive and unproven “stem cell treatments” for conditions where no approved therapy exists. These should be approached with great care. The ethical legitimacy of adult and iPSC methods does not mean that every clinic offering them is safe or honest. As in all things, the believer should seek wise counsel, qualified medical advice, and treatments grounded in genuine evidence.
VIII. Conclusion: No False Choice
The world often presents the Christian with what appears to be a cruel dilemma: cling to your principles and forgo the healing that science offers, or set your conscience aside for the sake of your health. In the matter of stem cells, that dilemma is false. The methods that destroy human life have proven, after decades and vast expense, to be the least fruitful. The methods that honor the sanctity of life — adult stem cells and induced pluripotent stem cells — are the ones actually restoring sight, curing cancers, and rebuilding broken bodies.
This should not surprise us. The God who knit us together in the womb, and who declared every stage of that knitting to be the forming of a person known to Him, has not left His people to choose between obedience and healing. The believer can pursue the best of modern medicine and keep a clear conscience before God, refusing the one path that requires the blood of the innocent and walking freely in the two that do not.
Sources and Further Reading
- The Holy Bible (King James Version) — Psalm 139; Jeremiah 1:5; Luke 1:44; Romans 3:8; 1 Corinthians 10:31.
- Takahashi K. & Yamanaka S., “Induction of pluripotent stem cells…,” Cell (2006). The original iPSC discovery.
- “Two decades of induced pluripotent stem cell research,” Cell Stem Cell (2026).
- “Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease,” Nature (2025).
- “Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery,” The Lancet (2024).
- Thomas L. et al., systematic scoping review of iPSC clinical studies, Cytotherapy (2026).
- U.S. Food and Drug Administration, “Approved Cellular and Gene Therapy Products” (2025).
- “Ethical Issues in Stem Cell Research,” National Institutes of Health / PMC.
- “A Scientist’s View of the Ethics of Human Embryonic Stem Cell Research,” Cell Stem Cell (2007).
- International Society for Stem Cell Research statements on NIH hESC funding (2026).
- Harvard Stem Cell Institute, “Examining the ethics of embryonic stem cell research.”